Achintya K Bhowmik

Dr. Achintya K Bhowmik

Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2024 in Journal of the Society for Information Display
Verified
Journal Article
Closed access
ABAchintya K Bhowmik
Achintya K Bhowmik

1 November 2017 in Journal of the Society for Information Display
Verified
Journal Article
Closed access
PDF file
KVKailas Vodrahalli
Kailas Vodrahalli
ABAchintya K Bhowmik
Achintya K Bhowmik

4 December 2024 in Audiology Research
Verified
Journal Article
Open access
PDF file
EMEdward Madara
Edward Madara
ABAchintya K Bhowmik
Achintya K Bhowmik
Despite the significant advancements in hearing aid technology, their adoption rates remain low, with stigma continuing to be a major barrier for many. This review aims to assess the origins and current state of hearing aid stigma, as well as explore potential strategies for alleviating it. This review examines the societal perceptions, psychological impacts, and recent technological advancements that can influence hearing aid adoption and reduce stigma. Methods: A narrative-focused review of the literature from peer-reviewed journals and reputable sources was conducted, analyzing papers on hearing aid stigma, adoption rates, and technological solutions. The research works were categorized based on their focus on the drivers and alleviation strategies for the stigma of hearing aids. Results: This review identifies stigma as a complex, multifaceted issue driven primarily by ageism, disability perception, and the association of hearing aids with aging and incapability. Despite technological improvements, the studies surveyed listed stigma as a major factor in non-adoption. Technological advancements such as artificial intelligence in sound processing, multifunctional features, and innovative design have shown potential in reducing stigma and improving user experience. Conclusions: Alleviating the stigma of hearing aids requires a multi-pronged approach, combining improvements in technology with changes in societal perceptions. Multifunctional devices including both health and communications functions, advanced signal processing, and esthetic improvements can drive their adoption, but broader public health awareness and education are also essential to changing societal attitudes and fostering greater acceptance of hearing aids.

19 November 2001 in Applied Physics Letters
Verified
Journal Article
Closed access
PDF file
ADAditya K. Dharmadhikari
Aditya K. Dharmadhikari
ABAchintya K Bhowmik
Achintya K Bhowmik
AAAyayi C. Ahyi
Ayayi C. Ahyi
MTMrinal Thakur
Mrinal Thakur
Highly efficient spectrally narrowed emission (SNE) was observed in the solution of strylpyridinium cyanine dye (SPCD) pumped by fundamental and second harmonic of a picosecond Nd:YAG laser in two separate arrangements. A highly directional emission was observed in both the pumping arrangements without incorporating any mirrors. The pulse duration of the SNE was measured by background free SHG intensity autocorrelation technique. The measured duration of the pulses was 40 ps. These pulses, having a spectral linewidth of 10 nm (full width at half maximum), were used as a probe to measure the transient changes in the transmission in SPCD solution using a pump–probe setup. The transient optical transmission indicated a gain at the overlap and no gain was observed beyond a delay of 40 ps.


2 February 2026 in AI
Verified
Journal Article
Open access
PDF file
RPRishab Parthasarathy
Rishab Parthasarathy
ABAchintya K Bhowmik
Achintya K Bhowmik
Despite significant medical advancements, cancer remains the second leading cause of death in the US, causing over 600,000 deaths per year. One emerging field, pathway analysis, is promising but still relies on manually derived wet lab data, which is time-consuming to acquire. This work proposes an efficient, effective, end-to-end framework for Artificial Intelligence (AI)-based pathway analysis that predicts both cancer severity and mutation progression in order to recommend possible treatments. The proposed technique involves a novel combination of time-series machine learning models and pathway analysis. First, mutation sequences were isolated from The Cancer Genome Atlas (TCGA) Database. Then, a novel preprocessing algorithm was used to filter key mutations by mutation frequency. This data was fed into a Recurrent Neural Network (RNN) that predicted cancer severity. The model probabilistically used the RNN predictions, information from the preprocessing algorithm, and multiple drug-target databases to predict future mutations and recommend possible treatments. This framework achieved robust results and Receiver Operating Characteristic (ROC) curves (a key statistical metric) with accuracies greater than 60%, similar to existing cancer diagnostics. In addition, preprocessing played a key role in isolating a few hundred key driver mutations per cancer stage, consistent with current research. Heatmaps based on predicted gene frequency were also generated, highlighting key mutations in each cancer. Overall, this work is the first to propose an efficient, cost-effective end-to-end framework for projecting cancer prognosis and providing possible treatments without relying on expensive, time-consuming wet lab work.